Stroke/Cerebrovascular Disease Perspective

 
 
  • We Have an Amputation Epidemic Changing the paradigm from "amputate first and ask questions later" will benefit patients with diabetes and is a key initiative of the American Diabetes Association.
  • AHA 2022 Does Lipoprotein(a) Play a Causal Role in ASCVD?   Michelle L. O'Donoghue, MD, MPH, and Stephen J. Nicholls, MBBS, PhD, discuss the evidence on lipoprotein(a) and its potential role in atherosclerosis and aortic stenosis.
  • Alcohol, Melatonin, and Other Top Clinical Topics of 2022 See which studies led to the most popular clinical topics of the year, with an infographic on each of the key findings.
  • Pemafibrate Didn't Improve CV Outcomes in Patients With T2D   Dr Anne Peters discusses the PROMINENT trial, which found that pemafibrate lowered triglycerides in patients with diabetes and hypertriglyceridemia but didn't improve cardiovascular outcomes.
  • Nov 18 2022 This Week in Cardiology   AHA 2022, Part 2: IRONMAN, ECMO-CS, CTS-AMI, and PROGRESSIVE AF are the trials John Mandrola, MD, reviews in this week’s podcast.
  • Percutaneous LAA Closure in Patients With AF   What considerations are involved in percutaneous LAA closure in stroke risk management for patients with AF? Drs Ashish Bhimani and Sandeep Goyal examine the evidence.
  • New Recommendations for Hyperglycemia Management   Much has changed in this consensus report on the use of glucose-lowering drugs in diabetes and it's relevant to primary care.
  • AHA 2022 Role of Ablation Type and Risk Factors in Paroxysmal AF   Jason Andrade gives details on the PROGRESSIVE-AF trial of cryoablation vs drugs in patients with paroxysmal AF, presented at the American Heart Association meeting.
  • Nov 11 2022 This Week in Cardiology   AHA 2022 Part 1: ISCHEMIA-EXTEND, STRONG-HF, chlorthalidone vs HCTZ, experts vs practitioners; torsemide vs furosemide; and TG lowering are discussed by John Mandrola, MD, in this week’s podcast.
  • Gisele Barreto Fetterman is a Hero The stakes are simply too high for this lesson from Fetterman's story to be drowned out by political noise.
  • AHA 2022 HCTZ vs Chlorthalidone -- A Win for Practicing Doctors and Science In the Diuretic Comparison Project, hydrochlorothiazide held its own compared with chlorthalidone as first-line hypertension agent despite U.S. experts' preference for the latter -- a lesson for us all, writes John Mandrola, MD.
  • Nov 4 2022 This Week in Cardiology   AF conversion in the ED, HRT, a shining example of evidence-based medicine and less-is-more, multimorbidity, and what’s coming at AHA are the topics John Mandrola, MD, covers in this week’s podcast.
  • Caring for the Aging Transgender Patient K. Ashley Brandt, DO, discusses often overlooked care options for older transgender patients as their numbers continue to grow.
  • WSC 2022 Read clinically focused news coverage of key developments from WSC 2022
  • Oct 28 2022 This Week in Cardiology   ERASE AF follow-up, recreational drugs and AF, etripamil, misuse of science, and diabetes as a cardiovascular risk factor are the topics John Mandrola, MD, discusses in this week's podcast.
  • Oct 21 2022 This Week in Cardiology   The ERASE AF ablation trial, left bundle pacing, finerenone, and perceptions of cardiology are the topics John Mandrola, MD, discusses in this week’s podcast.
  • The Latest Migraine Therapies -- Some You Might Not Know About   A headache specialist shares tips on using CGRP receptor antagonists and other effective options for patients with migraine.
  • Treating the Person: The Mind-Body-Heart Connection   The evidence underscores how psychological health contributes not only in a negative way to cardiovascular disease but also in a positive way to better cardiovascular health and reduced cardiovascular risk.
  • New Strategies for Medication Overuse Headache Treatment   Drs Marmura and Diener share clinical insights and discuss potential therapies for this condition.
  • The Surgeon's Approach to AF   Electrophysiologist John Mandrola and cardiac surgeon Rich Whitlock discuss surgical left atrial appendage closure and other surgical approaches to atrial fibrillation.